Kevin C Oboyle - Net Worth and Insider Trading
Kevin C Oboyle Net Worth
The estimated net worth of Kevin C Oboyle is at least $4 Million dollars as of 2024-05-13. Kevin C Oboyle is the Director of GenMark Diagnostics Inc and owns about 103,550 shares of GenMark Diagnostics Inc (GNMK) stock worth over $2 Million. Kevin C Oboyle is the Director of ZELTIQ Aesthetics Inc and owns about 11,985 shares of ZELTIQ Aesthetics Inc (ZLTQ) stock worth over $676,913. Kevin C Oboyle is also the Director of Wright Medical Group NV and owns about 12,390 shares of Wright Medical Group NV (WMGI) stock worth over $371,452. Besides these, Kevin C Oboyle also holds Nevro Corp (NVRO) , NuVasive Inc (NUVA) , Sientra Inc (SIENQ) . Details can be seen in Kevin C Oboyle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kevin C Oboyle has not made any transactions after 2021-12-14 and currently still holds the listed stock(s).
Transaction Summary of Kevin C Oboyle
Kevin C Oboyle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin C Oboyle owns 6 companies in total, including Sientra Inc (SIENQ) , GenMark Diagnostics Inc (GNMK) , and Nevro Corp (NVRO) among others .
Click here to see the complete history of Kevin C Oboyle’s form 4 insider trades.
Insider Ownership Summary of Kevin C Oboyle
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SIENQ | Sientra Inc | 2019-06-07 | director |
| GNMK | GenMark Diagnostics Inc | 2020-05-29 | director |
| NVRO | Nevro Corp | 2021-12-14 | director |
 | | 2019-07-26 | director |
| | 2017-04-28 | director |
| | 2009-12-15 | VP & Finance and CFO |
Kevin C Oboyle Latest Holdings Summary
Kevin C Oboyle currently owns a total of 6 stocks. Among these stocks, Kevin C Oboyle owns 103,550 shares of GenMark Diagnostics Inc (GNMK) as of March 6, 2020, with a value of $2 Million and a weighting of 65.4%. Kevin C Oboyle owns 11,985 shares of ZELTIQ Aesthetics Inc (ZLTQ) as of September 15, 2016, with a value of $676,913 and a weighting of 17.78%. Kevin C Oboyle also owns 12,390 shares of Wright Medical Group NV (WMGI) as of March 1, 2019, with a value of $371,452 and a weighting of 9.76%. The other 3 stocks Nevro Corp (NVRO) , NuVasive Inc (NUVA) , Sientra Inc (SIENQ) have a combined weighting of 7.06% among all his current holdings.
Latest Holdings of Kevin C Oboyle
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GNMK | GenMark Diagnostics Inc | 2020-03-06 | 103,550 | 24.04 | 2,489,342 |
| ZLTQ | ZELTIQ Aesthetics Inc | 2016-09-15 | 11,985 | 56.48 | 676,913 |
| WMGI | Wright Medical Group NV | 2019-03-01 | 12,390 | 29.98 | 371,452 |
| NVRO | Nevro Corp | 2021-12-14 | 13,318 | 10.19 | 135,710 |
| NUVA | NuVasive Inc | 2009-12-15 | 3,338 | 39.75 | 132,686 |
| SIENQ | Sientra Inc | 2019-06-07 | 5,377 | 0.03 | 161 |
Holding Weightings of Kevin C Oboyle
Kevin C Oboyle Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin C Oboyle has made a total of 2 transactions in GenMark Diagnostics Inc (GNMK) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in GenMark Diagnostics Inc is the acquisition of 10,800 shares on March 6, 2020, which cost Kevin C Oboyle around $48,924.
According to the SEC Form 4 filings, Kevin C Oboyle has made a total of 0 transactions in ZELTIQ Aesthetics Inc (ZLTQ) over the past 5 years. The most-recent trade in ZELTIQ Aesthetics Inc is the sale of 7,500 shares on September 15, 2016, which brought Kevin C Oboyle around $300,600.
According to the SEC Form 4 filings, Kevin C Oboyle has made a total of 0 transactions in Wright Medical Group NV (WMGI) over the past 5 years. The most-recent trade in Wright Medical Group NV is the sale of 6,417 shares on March 1, 2019, which brought Kevin C Oboyle around $205,344.
More details on Kevin C Oboyle's insider transactions can be found in the Insider Trading History of Kevin C Oboyle table.Insider Trading History of Kevin C Oboyle
- 1
Kevin C Oboyle Trading Performance
GuruFocus tracks the stock performance after each of Kevin C Oboyle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin C Oboyle is 35.03%. GuruFocus also compares Kevin C Oboyle's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin C Oboyle within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin C Oboyle's insider trading performs compared to the benchmark.
Performance of Kevin C Oboyle
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.11 | | | | | |
| Relative Return to S&P 500(%) | 9.55 | | | | | |
Kevin C Oboyle Ownership Network
Kevin C Oboyle Owned Company Details
What does Sientra Inc do?
Who are the key executives at Sientra Inc?
Kevin C Oboyle is the director of Sientra Inc. Other key executives at Sientra Inc include director & President and CEO Ronald Menezes , General Counsel and VP Oliver Christian Bennett , and Chief Financial Officer Andrew C Schmidt .
Sientra Inc (SIENQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sientra Inc (SIENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sientra Inc (SIENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sientra Inc (SIENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sientra Inc Insider Transactions
Kevin C Oboyle Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin C Oboyle. You might contact Kevin C Oboyle via mailing address: 5964 La Place Court, Carlsbad Ca 92008.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
